Solutions

By phase — BA-BE through IV

From bioequivalence studies and first-in-human dose escalation to post-marketing surveillance. The same schema carries the study through every phase.

Book a demo Explore the platform

BA-BE: pre-built templates, replicate-design support, intensive PK sampling.

Phase II/III: multi-site scale, RBQM, and central monitoring.

Phase IV: long-running follow-up at scale, low-friction site burden.

24 hours

To get a demo running on your own protocol

No scoping call, no quote and no purchase order first.

No code

To build your forms, checks and visit schedule

Doing it by hand takes most teams 4–8 weeks.

One

Data model behind every module

Enter data once and it is everywhere. Nothing to match up later.

Zero

Extra fees per form, per query or per export

The price is the same whether you collect 10 records or 10,000.

Other ways teams use Trialion

Bioequivalence (BA-BE) specialists

Replicate designs and intensive PK sampling, without a second system. Pre-built templates, volunteer randomization tied to dispensing, and ANDA-ready exports from the same data model.

Learn more

Generic-drug CROs

Short, focused trials, run at volume. Repeat protocol designs set up in days, priced per study or per month, with the whole portfolio on one data model.

Learn more

Multi-therapy CROs

Phase II to IV across therapeutic areas, on one data model. Configurable workflows and a single continuous audit trail, whatever the indication.

Learn more